News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,266 Results
Type
Article (44330)
Company Profile (325)
Press Release (673611)
Section
Business (211103)
Career Advice (2103)
Deals (36722)
Drug Delivery (105)
Drug Development (84000)
Employer Resources (173)
FDA (16620)
Job Trends (15439)
News (357660)
Policy (34071)
Tag
Academia (2663)
Alliances (51634)
Alzheimer's disease (1348)
Approvals (16599)
Artificial intelligence (225)
Bankruptcy (369)
Best Places to Work (11817)
Biotechnology (216)
Breast cancer (233)
Cancer (1824)
Cardiovascular disease (139)
Career advice (1756)
CAR-T (132)
Cell therapy (379)
Clinical research (67554)
Collaboration (710)
Compensation (384)
COVID-19 (2742)
C-suite (175)
Data (1704)
Diabetes (225)
Diagnostics (6402)
Earnings (87496)
Employer resources (148)
Events (114741)
Executive appointments (596)
FDA (17578)
Funding (633)
Gene therapy (267)
GLP-1 (695)
Government (4545)
Healthcare (19112)
Infectious disease (2869)
Inflammatory bowel disease (132)
Interviews (326)
IPO (16798)
Job creations (4064)
Job search strategy (1501)
Layoffs (472)
Legal (8379)
Lung cancer (266)
Manufacturing (256)
Medical device (13368)
Medtech (13373)
Mergers & acquisitions (20303)
Metabolic disorders (592)
Neuroscience (1784)
NextGen: Class of 2025 (6710)
Non-profit (4566)
Northern California (2188)
Obesity (325)
Opinion (224)
Patents (178)
People (59069)
Phase I (21037)
Phase II (29721)
Phase III (22198)
Pipeline (788)
Postmarket research (2686)
Preclinical (8960)
Radiopharmaceuticals (253)
Rare diseases (345)
Real estate (6254)
Regulatory (22988)
Research institute (2425)
Resumes & cover letters (360)
Southern California (1879)
Startups (3763)
United States (19426)
Vaccines (694)
Weight loss (229)
Date
Today (62)
Last 7 days (841)
Last 30 days (2701)
Last 365 days (35056)
2025 (5414)
2024 (36010)
2023 (40891)
2022 (52116)
2021 (56667)
2020 (55148)
2019 (47676)
2018 (35983)
2017 (33384)
2016 (32953)
2015 (38840)
2014 (32730)
2013 (27853)
2012 (29978)
2011 (30709)
2010 (28739)
Location
Africa (799)
Arizona (219)
Asia (40905)
Australia (6610)
California (5006)
Canada (1755)
China (422)
Colorado (230)
Connecticut (235)
Europe (87561)
Florida (733)
Georgia (171)
Illinois (474)
Indiana (279)
Maryland (776)
Massachusetts (3849)
Michigan (202)
Minnesota (346)
New Jersey (1419)
New York (1432)
North Carolina (878)
Northern California (2188)
Ohio (174)
Pennsylvania (1137)
South America (1171)
Southern California (1879)
Texas (737)
Utah (155)
Washington State (492)
718,266 Results for "immune pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Startups
GSK-backed Ouro Launches With $120M to ‘Reset’ the Immune System
Ouro is planning to leverage T cell engagers to deplete B cells and “reset” the immune system to treat immune-mediated diseases.
January 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases
December 20, 2024
·
8 min read
Press Releases
Immunic, Inc. to Participate in Investor Conference in December
November 26, 2024
·
5 min read
Mergers & acquisitions
Nasdaq Neophytes Acelyrin, Alumis Merge to Tackle Immune-Mediated Diseases
Alumis held its initial public offering in June last year, while Acelyrin debuted on the Nasdaq in mid-2023.
February 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)
February 6, 2025
·
5 min read
Press Releases
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
October 16, 2024
·
6 min read
Business
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. announced financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 8, 2024
·
14 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
Cellistic Launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development
February 17, 2025
·
2 min read
Press Releases
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
July 24, 2024
·
7 min read
1 of 71,827
Next
